These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30809185)

  • 1. Brain Iron Accumulation in Atypical Parkinsonian Syndromes:
    Lee JH; Lee MS
    Front Neurol; 2019; 10():74. PubMed ID: 30809185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.
    Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH
    J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron deposition in Parkinsonisms: A Quantitative Susceptibility Mapping study in the deep grey matter.
    Fedeli MP; Contarino VE; Siggillino S; Samoylova N; Calloni S; Melazzini L; Conte G; Sacilotto G; Pezzoli G; Triulzi FM; Scola E
    Eur J Radiol; 2020 Dec; 133():109394. PubMed ID: 33190103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
    Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
    Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated Differentiation of Atypical Parkinsonian Syndromes Using Brain Iron Patterns in Susceptibility Weighted Imaging.
    Kim YS; Lee JH; Gahm JK
    Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of susceptibility-weighted imaging in Parkinson's disease and atypical Parkinsonian disorders.
    Wang Z; Luo XG; Gao C
    Transl Neurodegener; 2016; 5():17. PubMed ID: 27761236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian Disorders.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Kremser C; Wildauer M; Schocke M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    J Parkinsons Dis; 2019; 9(4):681-691. PubMed ID: 31450511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
    J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative susceptibility mapping differentiates between parkinsonian disorders.
    Sjöström H; Granberg T; Westman E; Svenningsson P
    Parkinsonism Relat Disord; 2017 Nov; 44():51-57. PubMed ID: 28886909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
    Yekhlef F; Ballan G; Macia F; Delmer O; Sourgen C; Tison F
    J Neural Transm (Vienna); 2003 Feb; 110(2):151-69. PubMed ID: 12589575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint.
    Kaindlstorfer C; Jellinger KA; Eschlböck S; Stefanova N; Weiss G; Wenning GK
    J Alzheimers Dis; 2018; 61(4):1253-1273. PubMed ID: 29376857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging.
    Savoiardo M
    Neurol Sci; 2003 May; 24 Suppl 1():S35-7. PubMed ID: 12774211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification.
    Huppertz HJ; Möller L; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Respondek G; Stamelou M; Schnitzler A; Pinkhardt EH; Oertel WH; Knake S; Kassubek J; Höglinger GU
    Mov Disord; 2016 Oct; 31(10):1506-1517. PubMed ID: 27452874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
    Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y
    Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of GRE, ADC and routine MRI in distinguishing Parkinsonian disorders.
    Wadia PM; Howard P; Ribeirro MQ; Robblee J; Asante A; Mikulis DJ; Lang AE
    Can J Neurol Sci; 2013 May; 40(3):389-402. PubMed ID: 23603177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron metabolism in Parkinsonian syndromes.
    Berg D; Hochstrasser H
    Mov Disord; 2006 Sep; 21(9):1299-310. PubMed ID: 16817199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of gray matter atrophy in atypical parkinsonism syndromes: a VBM meta-analysis.
    Yu F; Barron DS; Tantiwongkosi B; Fox P
    Brain Behav; 2015 Jun; 5(6):e00329. PubMed ID: 26085961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis across a cohort of "atypical" atypical and complex parkinsonism.
    Malaquias MJ; Igreja L; Nogueira C; Pereira C; Vilarinho L; Quelhas D; Freixo JP; Oliveira J; Magalhães M
    Parkinsonism Relat Disord; 2023 Jun; 111():105408. PubMed ID: 37105015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis of parkinsonian syndromes using dopamine transporter and perfusion SPECT.
    Takaya S; Sawamoto N; Okada T; Okubo G; Nishida S; Togashi K; Fukuyama H; Takahashi R
    Parkinsonism Relat Disord; 2018 Feb; 47():15-21. PubMed ID: 29157745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.
    Vintonyak O; Gorges M; Müller HP; Pinkhardt EH; Ludolph AC; Huppertz HJ; Kassubek J
    Neurodegener Dis; 2017; 17(4-5):117-126. PubMed ID: 28268209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.